Bandage innovation aims to kill without breeding resistance

Link: Quick-Med Technologies

    In the article, Dr. Schultz stated that Quick-Med Technologies' bandages may help reduce the risk of infection as well as minimize outbreaks of drug-resistant staph infections. Unlike other antibacterial products, NIMBUS-based dressings are designed to promote healing while preventing bacteria from developing resistance. Drug resistant bacteria, such as VRE (Vancomycin-Resistant Enterococcus) and MRSA (Methicillin-Resistant Staphylococcus aureus) are a growing concern in healthcare facilities where risks of prolonged illness and fatality due to so-called "Super Bugs" have risen sharply. Quick-Med Technologies is pursuing ongoing research and regulatory approvals for its medical devices or related products. "Because of the vast number of bacteria that we come into contact with every day, there is a significant need for products that can help reduce the number of infections that are caused by these contacts" stated Dr. Schultz. "On behalf of my colleagues at QMT who have greatly contributed to the advancement of the NIMBUS technology, I am honored to be named an Innovator by TIME magazine."